Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2026-09-21).
No Canadian shortage report is currently matched to this DIN.
| NOC | Date | Submission | Reason |
|---|
| 22600 | 2019-09-05 | Supplement to a New Drug Submission (SNDS) | ADDITION OF AN ALTERNATE DRUG MANUFACTURING AND TESTING SITE |
| 20429 | 2018-02-02 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 20254 | 2018-01-08 | Supplement to a New Drug Submission (SNDS) | CHANGE TO PRESCRIPTION STATUS. LABELLING UPDATES |
| 14212 | 2013-03-13 | Supplement to a New Drug Submission (SNDS) | New species - Honey bees; New indication |
| 8615 | 2007-02-23 | Supplement to a New Drug Submission (SNDS) | CHANGE IN PRE-SLAUGHTER WITHDRAWAL PERIOD (BROILER CHICKENS) |
| 8400 | 2006-11-08 | Supplement to a New Drug Submission (SNDS) | FOR A RANGE DOSAGE APPROVAL FROM 110 PPM TO 150 PPM FOR THE INDICATION OF NECROTIC ENTERITIS (NE) CAUSED BY CLOSTRIDIUM PERFRINGENS IN BROILER CHICKENS |
| 8281 | 2006-09-22 | Supplement to a New Drug Submission (SNDS) | CHANGE IN THE PRE-SLAUGHTER WITHDRAWAL PERIOD (PIGS) |
| 5323 | 2004-08-31 | Supplement to a New Drug Submission (SNDS) | ADDITIONAL CLAIM FOR SWINE: AS AN AID IN THE TREATMENT OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) OR ILEITIS ASSOCIATED WITH LAWSONIA INTRACELLULARIS |
| 3618 | 2003-01-24 | Supplement to a New Drug Submission (SNDS) | AS AN AID IN THE TREATMENT OF NECROTIC ENTERITIS CAUSED BY CLOSTRIDIUM PERFRINGENS IN BROILER CHICKENS |